Back to search

Presentation of renal tumor antigens by human dendritic cells activates tumor-infiltrating lymphocytes against autologous tumor: implications for live kidney cancer vaccines.

Data up to Jan 2025

Published1999
Citations71
References38

Total Citations Per Year

Abstract

References (38)

The Dendritic Cell System and its Role in Immunogenicity

1991 • 4,733 citations

Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation.

1996 • 2,032 citations

Proliferating dendritic cell progenitors in human blood.

1994 • 1,922 citations

Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells

1996 • 1,908 citations

Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells

1996 • 1,854 citations

Generation of mature dendritic cells from human blood An improved method with special regard to clinical applicability

1996 • 1,138 citations

Human neoplasms elicit multiple specific immune responses in the autologous host.

1995 • 1,097 citations

High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10.

1996 • 959 citations

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.

1996 • 849 citations

Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity.

1996 • 746 citations

Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood

1996 • 696 citations

Decreased antigen presentation by dendritic cells in patients with breast cancer.

1997 • 439 citations

Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen

1996 • 398 citations

Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma.

1993 • 385 citations

Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells.

1995 • 324 citations

Induction of antitumor immunity using bone marrow-generated dendritic cells.

1996 • 323 citations

Generation of Mature Dendritic Cells from Human Blood

1997 • 297 citations

Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts

1997 • 209 citations

Human CD14+ leukocytes acquire the phenotype and function of antigen-presenting dendritic cells when cultured in GM-CSF and IL-4

1996 • 199 citations

Mechanisms of immune suppression in patients with head and neck cancer: Influence on the immune infiltrate of the cancer

1996 • 178 citations

Inflammatory cells infiltrating human colorectal carcinomas express HLA class II but not B7-1 and B7-2 costimulatory molecules of the T-cell activation.

1996 • 160 citations

S100 positive dendritic cells in human lung tumors associated with cell differentiation and enhanced survival

1993 • 160 citations

Human renal-cell carcinoma tissue contains dendritic cells

1996 • 152 citations

Bone Marrow‐Derived Dendritic Cells Serve as Potent Adjuvants for Peptide‐Based Antitumor Vaccines

1997 • 144 citations

Presentation of prostate tumor antigens by dendritic cells stimulates T-cell proliferation and cytotoxicity

1996 • 120 citations

Interleukin-12 Promotes the Proliferation and Cytolytic Maturation of Immune Effectors

1993 • 101 citations

TGF-β1 pretreatment impairs the allostimulatory function of human bone marrow-derived antigen-presenting cells for both naive and primed T cells

1996 • 72 citations

Anticancer role of dendritic cells (DC) in human and experimental cancers--a review.

1992 • 60 citations

Tumor antigens and tumor vaccines: Peptides as immunogens

1996 • 48 citations

CD4+ T-cells from mice immunized to syngeneic sarcomas recognize distinct, non-shared tumor antigens.

1994 • 44 citations

Liposome-Mediated Cytoplasmic Delivery of Proteins: An Effective Means of Accessing the MHC Class I-Restricted Antigen Presentation Pathway

1994 • 41 citations

Regional immunosuppression in esophageal squamous cancer: evidence from functional studies with matched lymph nodes.

1996 • 41 citations

In vitro migration of lymphocytes through collagen matrix: arrested locomotion in tumor-infiltrating lymphocytes.

1990 • 38 citations

Dendritic cells as specialized antigen-presenting cells

1989 • 33 citations

Renal cell carcinoma: basic biology and current approaches to therapy.

1991 • 32 citations

Cellular therapy: scientific rationale and clinical results in the treatment of metastatic renal-cell carcinoma.

1995 • 31 citations

Differential Activation of Cell-Mediated Immune Functions by Encapsulated and Surface-Linked Liposomal Antigens

1996 • 25 citations

Cytotoxic Activity of CD4+ T Cells against Autologous Tumor Cells

1995 • 11 citations

Cited By (0)

No citing papers found in database

Presentation of renal tumor antigens by human dendritic cells activates… (1999) – PubMed | Metascience Observatory Explorer